BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//DASCS - ECPv4.9.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:DASCS
X-ORIGINAL-URL:http://dascs.dk
X-WR-CALDESC:Events for DASCS
BEGIN:VTIMEZONE
TZID:"Europe/Copenhagen"
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260423
DTEND;VALUE=DATE:20260425
DTSTAMP:20260316T154852
CREATED:20251108T080421Z
LAST-MODIFIED:20251108T080421Z
UID:1942-1776902400-1777075199@dascs.dk
SUMMARY:Latest Advances in Stem Cell-Based Disease Modelling and Drug Screening
DESCRIPTION:We are excited to announce that registration is now open for the upcoming stem cell symposium Latest Advances in Stem Cell-Based Disease Modelling and Drug Screening\, co-organised by StemScreen and DASCS. \nThis vibrant event will bring together leading scientists in stem cell research\, disease modelling\, and drug discovery to share their latest breakthroughs and foster collaboration across academia\, biotech\, and pharma. \nSpeakers \n\nChristine Mummery – Professor of Developmental Biology\, NNF Center for Stem Cell Medicine – reNEW and Leiden University Medical Center\, The Netherlands\nLorenz Studer – Founding Director\, SKI Center for Stem Cell Biology and Enid A. Haupt Chair in Developmental Biology\, Memorial Sloan Kettering Cancer Center\, USA\nLudovic Vallier – Einstein Professor for Stem Cells in Regenerative Therapies\, Berlin Institute of Health @Charité and Max Planck Institute for Molecular Genetics\, Germany\nPeter Reinhardt – Principal Research Scientist II / Team Lead\, Advanced Cell Technologies and Screening\, Neuroscience Discovery Research\, AbbVie\, Germany\nLauriane Cabon – Group Lead – Applied Organoid Technologies\, Roche Institute of Human Biology\, Switzerland\nMalene Ambjørn – Director\, Functional & Cellular Pharmacology\, Neuroscience\, Lundbeck\, Denmark\nHenning Kempf – Head of Department\, GEM CELL Hub\, Novo Nordisk\, Denmark\nMore speakers to be announced\n\nHighlights \n\nCutting-edge research on stem cell-derived disease models\nAdvances in organoid technology and 3D culture systems\nScalable platforms for drug screening and lead compound testing\nStrategies for drug discovery and translation\n\nWhy Attend \n\nEngage with world-renowned experts and emerging voices\nDiscover new tools and technologies shaping the future of drug discovery\nNetwork with peers and potential collaborators\nBecome an abstract selected presenter to showcase your own research\n\nJoin us in Copenhagen to explore how stem cell technologies are redefining the landscape of biomedical research and therapeutic innovation. \nRegistration \nRegistration deadline: 20 February 2026 \n
URL:http://dascs.dk/?tribe_events=latest-advances-in-stem-cell-based-disease-modelling-and-drug-screening
LOCATION:Faculty of Health and Medical Sciences\, University of Copenhagen\, Blegdamsvej 3B\, Copenhagen\, 2200\, Denmark
ATTACH;FMTTYPE=image/jpeg:http://dascs.dk/wp-content/uploads/2025/11/StemScreenSymposium2026Flyer_1200x1200_20251106-e1765312635312.jpg
END:VEVENT
END:VCALENDAR